Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Roche Diagnostics cobas Liat SARS-CoV-2 + Influenza A/B Control Kit

Catalog No. 23312206
Click to view available options
Quantity:
3 Sets of Controls/Kit
This item is not returnable. View return policy
Order eligibility is based upon executed contractual agreement.
This item is not returnable. View return policy
Order eligibility is based upon executed contractual agreement.

The cobas SARS-CoV-2 & Influenza A/B nucleic acid test is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, Influenza A, and Influenza B. This control kit is for running a control test/lot validation for the assay.

  • One sample one test, 20 minutes, know if it's COVID-19 or flu
  • Take the workload out of testing with a simple intuitive user handling
  • Minimizes cross-contamination and risk of exposure during testing with the closed-system design
  • Control Kit for use with SARS-CoV-2 & Influenza A/B Assay
  • SARS-CoV-2: 100% Positive Agreement, 100% Negative Agreement*

*Compared to an FDA-cleared EUA, cobas SARS-CoV-2 Test on cobas 6800/8800 systems

TRUSTED_SUSTAINABILITY

Specifications

Certifications/Compliance CE/EUA
Content And Storage 2°C to 8°C
Control Sets This control product to be used with cobas™ SARS-CoV-2 & Influenza A/B assay
CE Marker Yes
Type Control
Disposable Single-use
For Use With (Application) RT-PCR
Packaging Type 1 Kit
Quantity 3 Sets of Controls/Kit
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.